No contravention by Sun Pharma in Sale of FluGuard 400mg tablet: CCI

Ashwani Kumar Singla Vs Sun Pharmaceutical Industries Limited (Competition Commission of India)

The Commission observes that while determination of price of a drug and the aspects pertaining to its labeling may not be in the domain of the Commission, however, any unfair or discriminatory conduct in relation thereto by a dominant entity can be assessed by it, provided that the facts disclose a violation of the relevant provisions of the Act.

The Commission notes from public

Please become a Premium member. If you are already a Premium member, login here to access the full content.